logo

Intravascular Ultrasound Systems (IVUS)-Medical Devices Pipeline Assessment, 2017

Region:Global

Product Code:GDME0404EPD

Download Sample Report
Published On

August 2017

Total pages

69

About the Report

Intravascular Ultrasound Systems (IVUS)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Intravascular Ultrasound Systems (IVUS)-Medical Devices Pipeline Assessment, 2017" provides an overview of Intravascular Ultrasound Systems (IVUS) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Intravascular Ultrasound Systems (IVUS) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Intravascular Ultrasound Systems (IVUS) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Intravascular Ultrasound Systems (IVUS) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Intravascular Ultrasound Systems (IVUS) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

Scope of the Report

Products

Arbor Ultrasound Technologies, LLC (Inactive), Carotid Ultrasound Imaging System; Biosense Webster Inc, 3D Ultrasound Next Generation Catheter; Boston Scientific Corp, iSight / MDU5+; Conavi Medical Inc., Intravascular Imaging Catheter; Covidien plc, Covidien SeeHawk; Georgia Institute of Technology, Catheter-Based Device; North Carolina State University, Intravascular Ultrasound Transducers; OCT Medical Imaging Inc, IVUS-OCT Imaging System; RadioSon Corporation, Intravascular Ultrasound-Imaging Catheter; SIBUS Medical, Inc., Intravascular Ultrasound Imaging System; Soundpipe LLC, Intravascular Ultrasound Catheter-Localized Drug Delivery; Terumo Corp, IVUS; University of Oxford, Intravascular Imaging Catheter; University of Texas at Austin, Photoacoustic Imaging Device-Cardiovascular Plaque; Vesselon Inc, Non-Invasive Ultrasound Device; Volcano Corp, Focused Acoustic Computed Tomography System; Volcano Corp, GIVUS; Volcano Corp, Mackinaw; Volcano Corp, NC VIBE Imaging Balloon Catheter; Volcano Corp, Next Generation Revolution Catheter; Volcano Corp, Preview Second Generation Forward Looking IVUS Catheter And System; Volcano Corp, Preview Third Generation FL.IVUS Platform; Volcano Corp, PV IVUS Co-Reg

Companies

Arbor Ultrasound Technologies, LLC

Biosense Webster Inc

Boston Scientific Corp

Conavi Medical Inc.

Covidien plc

Georgia Institute of Technology

North Carolina State University

OCT Medical Imaging Inc

RadioSon Corporation

SIBUS Medical, Inc.

Soundpipe LLC

Terumo Corp

University of Oxford

University of Texas at Austin

Vesselon Inc

Volcano Corp

Table of Contents

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 5

2 Introduction 6

2.1 Intravascular Ultrasound Systems (IVUS) Overview 6

3 Products under Development 7

3.1 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Stage of Development 7

3.2 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Segment 8

3.3 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Territory 9

3.4 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Regulatory Path 10

3.5 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Estimated Approval Date 11

4 Intravascular Ultrasound Systems (IVUS)-Pipeline Products under Development by Companies 12

4.1 Intravascular Ultrasound Systems (IVUS) Companies-Pipeline Products by Stage of Development 12

4.2 Intravascular Ultrasound Systems (IVUS)-Pipeline Products by Stage of Development 13

5 Intravascular Ultrasound Systems (IVUS) Companies and Product Overview 14

5.1 Arbor Ultrasound Technologies, LLC (Inactive) Company Overview 14

5.1.1 Arbor Ultrasound Technologies, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 14

5.2 Biosense Webster Inc Company Overview 15

5.2.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.3 Boston Scientific Corp Company Overview 16

5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 16

5.4 Conavi Medical Inc. Company Overview 17

5.4.1 Conavi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 17

5.5 Covidien plc Company Overview 18

5.5.1 Covidien plc Pipeline Products & Ongoing Clinical Trials Overview 18

5.6 Georgia Institute of Technology Company Overview 19

5.6.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 19

5.7 North Carolina State University Company Overview 20

5.7.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 20

5.8 OCT Medical Imaging Inc Company Overview 21

5.8.1 OCT Medical Imaging Inc Pipeline Products & Ongoing Clinical Trials Overview 21

5.9 RadioSon Corporation Company Overview 22

5.9.1 RadioSon Corporation Pipeline Products & Ongoing Clinical Trials Overview 22

5.10 SIBUS Medical, Inc. Company Overview 23

5.10.1 SIBUS Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23

5.11 Soundpipe LLC Company Overview 24

5.11.1 Soundpipe LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.12 Terumo Corp Company Overview 25

5.12.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 25

5.13 University of Oxford Company Overview 26

5.13.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 26

5.14 University of Texas at Austin Company Overview 27

5.14.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 27

5.15 Vesselon Inc Company Overview 28

5.15.1 Vesselon Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.16 Volcano Corp Company Overview 29

5.16.1 Volcano Corp Pipeline Products & Ongoing Clinical Trials Overview 29

6 Intravascular Ultrasound Systems (IVUS)-Recent Developments 35

6.1 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 35

6.2 Jul 25, 2017: Catherine Estrampes appointed President & CEO of GE Healthcare Europe 36

6.3 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 37

6.4 Jun 19, 2017: Conavi Medical Welcomes Peter Wehrly to the Board of Directors 39

6.5 Jun 12, 2017: Kieran Murphy Appointed CEO of GE Healthcare, Succeeding John Flannery 40

6.6 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 40

6.7 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 43

6.8 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 44

6.9 Feb 09, 2017: Terumo Announces Change of Executive Officers 47

6.10 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 48

6.11 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 49

6.12 Jan 31, 2017: Terumo Opens a Branch in Yangon 50

6.13 Dec 12, 2016: Terumo Formulates 5-Year Mid-to Long-term Growth Strategy 50

6.14 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 51

6.15 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 54

6.16 Nov 15, 2016: NanoVibronix Provides Third Quarter 2016 Business Update 54

6.17 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 55

6.18 Nov 01, 2016: GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation 56

6.19 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 57

6.20 Oct 20, 2016: NanoVibronix Expands Senior Management Team and Board of Directors 58

6.21 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 59

6.22 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 61

6.23 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 61

6.24 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 62

7 Appendix 66

7.1 Methodology 66

7.2 About GlobalData 69

7.3 Contact Us 69

7.4 Disclaimer 69

Research Methodology

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022